Patient-level outcomes: Methodological considerations for retrospective data collected during a pandemic
From reduced access to preventive care to changes in adherence, a global pandemic can lead to significant changes in healthcare delivery and utilization. These shifts in utilization patterns may subsequently impact how health economics and outcomes researchers use retrospective data to evaluate patient outcomes from a methodological perspective.
Join Brenna Brady, PhD, and Joseph Tkacz, MS, lead researchers with IBM Watson Health Life Sciences, for a discussion of the potential implications of a global pandemic on the use of real-world data for outcomes research. Our presenters will discuss the possible indirect impacts of a pandemic on healthcare utilization, how this can impact the use of real-world data for outcomes research, and what adjustments researchers may need to make in their analyses in order to account for these changes.